# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-319022
Filing Date
2026-07-28
Accepted
2026-07-28 09:22:26
Documents
100
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | alks-20260630.htm iXBRL | 10-Q | 3893528
2 | EX-31.1 | alks-ex31_1.htm | EX-31.1 | 20155
3 | EX-31.2 | alks-ex31_2.htm | EX-31.2 | 20129
4 | EX-32.1 | alks-ex32_1.htm | EX-32.1 | 25173
5 | GRAPHIC | img19669778_0.jpg | GRAPHIC | 13021
6 | GRAPHIC | img19669778_1.jpg | GRAPHIC | 134869
7 | GRAPHIC | img19669778_2.gif | GRAPHIC | 120244
8 | GRAPHIC | img19669778_3.gif | GRAPHIC | 107826
9 | GRAPHIC | img19669778_4.gif | GRAPHIC | 10761
| Complete submission text file | 0001193125-26-319022.txt |  | 16621212

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alks-20260630.xsd | EX-101.SCH | 1769173
104 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20260630_htm.xml | XML | 3433811

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 261208011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)